Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine Dry Syrup vs Ketotifen in Children with Perennial Allergic Rhinitis
NCT00253058Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cetirizine in perennial allergic rhinitis (PAR) (2 arms), sponsored by GSK. Primary endpoint: Total Nasal Symptom Score. Started Jul 2005; status: completed.
02
Drugs
cetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00253058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253058.